Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial, Double-blind, Single-dose Drug and Escalating Infection Intensities, Evaluating the Safety and Efficacy of Moxidectin 2 mg, Ivermectin-controlled, in Loa Loa Microfilaremic Patients

NCT04049851 is registered in ClinicalTrials.gov with Center for Research on Filariasis and Other Tropical Diseases, Cameroon as lead sponsor.

NCT NCT04049851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial, Double-blind, Single-dose Drug and Escalating Infection Intensities, Evaluating the Safety and Efficacy of Moxidectin 2 mg, Ivermectin-controlled, in Loa Loa Microfilaremic Patients
Lead sponsor
Center for Research on Filariasis and Other Tropical Diseases, Cameroon
Phase
Phase 2
Overall status
Completed
Start date
April 7, 2022
Completion date
July 22, 2023
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

loiasis, onchocerciasis, ocular